SCOR Global Life, a division of the France-headquartered reinsurer, has announced a partnership with Human Longevity, Inc (HLI), a provider of in-depth and sophisticated health information services.
HLI aims to prevent, reduce or postpone the onset of preventable conditions by combining genome sequencing, machine learning, full-body MRI scans and blood samples with an overlay of tests correlated to genetic predisposition in order to assess “actual” risk.
“As data-driven health intelligence becomes more accessible and affordable, we see an opportunity to improve the health and well-being of policyholders by offering services that can help extend life expectancy,” said Michael Colannino, Executive Vice President and Chief Strategy Officer for SCOR Global Life in the Americas.
“As a reinsurer, we are eager to contribute to innovation that identifies health risks early and provides win-win outcomes.”
The partnership is part of SCOR Life & Health Ventures, which was established to create a community of trusted partners that will offer SCOR Global Life’s clients access to data-driven health services.
“We believe our partnership with SCOR Global Life will demonstrate the potential for these predictive models to improve risk management capabilities for the life insurance and reinsurance industries, with an even more inspiring benefit in the potential it has to help their clients live longer and healthier lives,” added Dr. David Karow, Interim Chief Executive Officer and Chief of Radiogenomics at Human Longevity, Inc.
